Quick-Med Technologies' Research & Development Center Moves to New Location

GAINESVILLE, Florida, February 12, 2008 - Quick-Med Technologies announced today that its Research & Development Center has moved to a new location in Gainesville, Florida. The new space, for which it has a 3-year lease, will offer larger on-site testing facilities to better service the needs of its customers and partners.

Announcing the move, Quick-Med Technologies' Vice President of R&D and Commercialization, Dr. Gerald M. Olderman, commented: "The new larger facility is close to the University of Florida, a working partner in the company's two core technologies, and will provide us with an excellent base to service both our current and planned future growth. We look forward to a faster pace of R&D now that we have the appropriate space."

Located in close proximity to downtown and its licensor, the University of Florida at Gainesville, the Research & Development Center has settled nicely into its new surroundings. The new address and phone number are as follows:

Quick-Med Technologies, Inc
Research & Development Center
902 NW 4th Street
Gainesville, Florida 32601-4285
Tel. (352) 379.0611
Fax (352) 379.1099

About Quick-Med Technologies, Inc.
Quick-Med Technologies is a life sciences company focused in developing proprietary, broad-based technologies for consumer, industrial, and healthcare use, as well as for advanced military and civilian medical applications. The Company¹s two core products under development are (1) MultiStat™, a family of advanced compounds shown to be effective in broad-based skin therapy applications, and (2) NIMBUS™, a family of advanced polymers that can be used in a wide range of applications from advanced wound care to wood preservatives. Quick-Med Technologies is listed under the symbol "QMDT" on the OTC Bulletin Board. For additional information, visit Quick-Med Technologies¹ website: www.quickmedtech.com or email: info@quickmed-technologies.com

For additional further information, please contact QMT:

David S. Lerner -- President
Phone : (561) 750-4202
Email: dlerner@quickmed-technologies.com

Natasha A. Sorobey -- Corporate & Investor Relations (Canada)
Phone: (403) 203-4748
Email: nsorobey@quickmed-technologies.com

Forward-looking statements (statements which are not historical facts) in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. For this purpose, any statements contained in this release that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as "may", "will", "to", "expect", "plan", "believe", "anticipate", "intend", "could", "would", "estimate", and/or "continue" or the negative or other variations thereof or comparable terminology is intended to identify forward-looking statements involve risks and uncertainties, including launch and approval of the potential products described herein and the Company¹s results of operations. The Company is also subject to other risks as detailed from time-to-time in the Company¹s SEC filings.